<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-151022" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chondroid Syringoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Meckley</surname>
            <given-names>Abigail L.</given-names>
          </name>
          <aff>HCA Florida Orange Park Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stepien</surname>
            <given-names>Angelia</given-names>
          </name>
          <aff>Orange Park Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abigail Meckley declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Angelia Stepien declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-151022.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chondroid syringoma, also known as a mixed tumor of the skin, is a rare, typically benign neoplasm that arises from the sweat glands in the skin. These tumors predominantly occur in the head and neck region, especially on the nose, cheeks, and upper lip, though they can also be found on the extremities.<xref ref-type="bibr" rid="article-151022.r1">[1]</xref><xref ref-type="bibr" rid="article-151022.r2">[2]</xref>&#x000a0;In 1892, Nasse described the histopathologic components of both epithelial and mesenchymal elements, resembling the structure of mixed tumors in other tissues, such as pleomorphic adenoma of the salivary gland.<xref ref-type="bibr" rid="article-151022.r3">[3]</xref>&#x000a0;The term chondroid syringoma was suggested by Hirsch and Helwig in 1961.<xref ref-type="bibr" rid="article-151022.r4">[4]</xref>&#x000a0;Chondroid syringomas generally grow slowly and present as painless, firm nodules. While most are benign, there have been rare cases of malignancy. Treatment typically involves surgical excision, and the prognosis is generally good following complete removal of the tumor.<xref ref-type="bibr" rid="article-151022.r5">[5]</xref></p>
      </sec>
      <sec id="article-151022.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of chondroid syringoma remains unclear, but it is believed to originate from pluripotent cells within the sweat gland ductal epithelium.<xref ref-type="bibr" rid="article-151022.r4">[4]</xref>&#x000a0;Some studies suggest a potential association with trauma, chronic irritation, or hormonal influences, although no definitive causal factors have been identified. Histologically, chondroid syringoma exhibits a biphasic pattern with both epithelial and mesenchymal components, characterized by nests of basaloid epithelial cells and areas of chondroid or myxoid stroma.<xref ref-type="bibr" rid="article-151022.r6">[6]</xref> While the tumor typically presents as a slow-growing, painless, solitary nodule, diagnosis primarily relies on histopathological examination. Although some recent developments have been made to identify genomic aberrations of various salivary gland tumors, further research is needed to elucidate the precise etiology and pathogenesis of chondroid syringoma.<xref ref-type="bibr" rid="article-151022.r7">[7]</xref></p>
      </sec>
      <sec id="article-151022.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Chondroid syringoma is a relatively uncommon benign tumor arising from sweat gland structures, most frequently observed in the head and neck area. While precise epidemiological data on chondroid syringoma are limited, this neoplasm predominantly affects adults, with a slight predominance in men.<xref ref-type="bibr" rid="article-151022.r4">[4]</xref>&#x000a0;The condition typically manifests between the third and sixth decades of life; pediatric cases have been reported.<xref ref-type="bibr" rid="article-151022.r8">[8]</xref><xref ref-type="bibr" rid="article-151022.r9">[9]</xref>&#x000a0;</p>
        <p>There is a consensus that chondroid syringoma is rare, comprising less than 0.01% of all primary skin tumors.<xref ref-type="bibr" rid="article-151022.r10">[10]</xref><xref ref-type="bibr" rid="article-151022.r11">[11]</xref>&#x000a0;Although it can occur sporadically, some reports suggest an association with previous trauma or chronic irritation at the tumor site. However, further research is warranted to establish more comprehensive epidemiological characteristics and risk factors associated with this condition.</p>
      </sec>
      <sec id="article-151022.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Mixed tumors of the skin originate from eccrine or apocrine sweat glands or their ductal structures.<xref ref-type="bibr" rid="article-151022.r3">[3]</xref>&#x000a0;The exact pathophysiological mechanisms underlying chondroid syringoma development remain unclear.&#x000a0;The condition&#x000a0;is believed to arise from pluripotent myoepithelial cells within the sweat gland ductal epithelium, undergoing differentiation towards both epithelial and mesenchymal components. The epithelial component usually consists of apocrine or eccrine differentiation, while the mesenchymal components are generally a chondroid or myxoid stroma.<xref ref-type="bibr" rid="article-151022.r12">[12]</xref>&#x000a0;Therefore, histologically, chondroid syringoma demonstrates a biphasic pattern characterized by nests of basaloid epithelial cells surrounded by a chondroid or myxoid stroma.</p>
        <p><italic toggle="yes">PLAG1</italic> gene rearrangements have been identified in a significant number of chondroid syringomas.<xref ref-type="bibr" rid="article-151022.r13">[13]</xref>&#x000a0;More than 87% of apocrine-type cutaneous mixed tumors overexpress <italic toggle="yes">PLAG1</italic>. However, eccrine-type cutaneous mixed tumors lack <italic toggle="yes">PLAG1</italic> expression.<xref ref-type="bibr" rid="article-151022.r12">[12]</xref>&#x000a0;Pleomorphic adenoma, chondroid syringoma's homologous neoplasm of the salivary gland, lung, and breast, also demonstrates <italic toggle="yes">PLAG1</italic> fusions.<xref ref-type="bibr" rid="article-151022.r12">[12]</xref></p>
        <p>Despite the limited understanding of its pathophysiology, chondroid syringoma is recognized as a benign tumor with low recurrence rates following surgical excision, underscoring its relatively indolent nature. Continued research efforts to unravel the molecular mechanisms driving chondroid syringoma development may provide insights into its pathophysiology and potentially identify novel therapeutic targets.</p>
      </sec>
      <sec id="article-151022.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Chondroid syringoma exhibits distinctive histopathological features that aid in its diagnosis (see <bold>Image.</bold> Cutaneous Mixed Tumor at 2x Magnification). Histologically, chondroid syringoma demonstrates a circumscribed dermal or subcutaneous tumor with a biphasic pattern characterized by nests or cords of basaloid epithelial cells surrounded by islands or strands of myoepithelial cells within a chondromyxoid or myxoid stroma.<xref ref-type="bibr" rid="article-151022.r13">[13]</xref><xref ref-type="bibr" rid="article-151022.r14">[14]</xref>&#x000a0;The basaloid cells typically form duct-like structures, while the myoepithelial cells appear spindled or stellate. A spectrum of differentiations exists for both the epithelial and stromal components. Epithelial alterations&#x000a0;include apocrine, eccrine, or less commonly follicular, sebaceous, or plasmacytoid differentiation. The various stromal components that have been identified include myxoid, chondroid, or less commonly collagenous, osteoid, or lipoid metaplasia.<xref ref-type="bibr" rid="article-151022.r15">[15]</xref>&#x000a0;</p>
        <p>Further, chondroid syringoma can be subclassified based on histologic characteristics into the most common apocrine type or the rarer eccrine type.<xref ref-type="bibr" rid="article-151022.r16">[16]</xref>&#x000a0;The apocrine variety typically involves differentiation toward hair follicle and sebaceous gland structures, with an epithelial part made up of branching tubules and cyst-like spaces set in a myxoid or chondromyxoid stroma (see <bold>Image.</bold> Cutaneous Mixed Tumor at 10x Magnification). The tubules consist of&#x000a0;2 layers: an outer layer of myoepithelial cells and an inner layer of epithelial cells, which sometimes exhibit secretion through decapitation.<xref ref-type="bibr" rid="article-151022.r17">[17]</xref>&#x000a0;In the eccrine type, the epithelial part consists of small tubes lined with&#x000a0;1 layer of uniform cells that are either cuboidal, oval, or round. These cells have a cytoplasm that is either eosinophilic or has a clear, glass-like appearance and vesicular nuclei. There is no decapitation secretion present.</p>
        <p>Immunohistochemical staining plays a valuable role in confirming the diagnosis of chondroid syringoma and distinguishing it from other cutaneous neoplasms. Commonly used immunohistochemical markers include cytokeratin, epithelial membrane antigen (EMA), S-100 protein, and smooth muscle actin (SMA). Cytokeratin and EMA typically show positive staining in the epithelial component of chondroid syringoma, highlighting the ductal structures. S-100 protein and SMA, on the other hand, demonstrate positive staining in the myoepithelial cells, aiding in identifying this component within the tumor.<xref ref-type="bibr" rid="article-151022.r12">[12]</xref>&#x000a0;The characteristic histopathological features and immunohistochemical staining patterns help accurately diagnose chondroid syringoma and differentiate it from other benign and malignant cutaneous neoplasms.</p>
      </sec>
      <sec id="article-151022.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical presentation of mixed tumors is indistinctive. These neoplasms can present with varying morphology but are most commonly misdiagnosed as cysts. The history and physical examination of a patient with chondroid syringoma play a critical role in diagnosis and management. Clinical evaluation typically involves a comprehensive assessment of the patient's medical history and a thorough examination of the lesion.</p>
        <p>History-taking should include inquiries about the lesion's onset, duration, progression, and associated symptoms, such as pain, tenderness, or changes in size. Patients may report a slow-growing, painless nodule present for months to years, often in the head and neck region, particularly around the eyelids or nose (see <bold>Image</bold>. Cutaneous Mixed Tumor). Additionally, clinicians should inquire about any relevant past medical history, including previous skin lesions, trauma, or radiation exposure.</p>
        <p>The physical examination of a chondroid syringoma typically&#x000a0;reveals a well-defined, firm, mobile nodule within the dermis or subcutaneous tissue. The overlying skin may appear normal or show erythematous, ulcerative, or crusting features. Lesions are often solitary but can occasionally be multiple. Size and location may vary, with some lesions being small and superficial while others may be larger and deeper-seated. While the history and physical examination provide valuable clues, definitive diagnosis typically requires histopathological examination of a tissue biopsy or excisional specimen.</p>
      </sec>
      <sec id="article-151022.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation typically involves a combination of clinical assessment, histopathological examination, and, in some cases, immunohistochemistry to confirm the diagnosis and assess the extent of the tumor. While there are no current guidelines and limited literature specifically addressing the evaluation of chondroid syringoma, recent studies have highlighted the role of various diagnostic modalities in its assessment. Histopathological examination remains the gold standard for diagnosing chondroid syringoma.<xref ref-type="bibr" rid="article-151022.r7">[7]</xref>&#x000a0;Tissue biopsy or excisional biopsy of the lesion allows for microscopic evaluation, revealing characteristic features such as nests of basaloid cells, tubular structures, and areas of chondroid or myxoid stroma. Fine-needle aspiration has also been reported as an initial biopsy method for deeper subcutaneous tumors.<xref ref-type="bibr" rid="article-151022.r18">[18]</xref><xref ref-type="bibr" rid="article-151022.r19">[19]</xref>&#x000a0;Immunohistochemistry may be utilized to support the diagnosis, with markers such as cytokeratin, EMA, and S-100 protein often showing positive staining patterns consistent with chondroid syringoma.</p>
        <p>Imaging studies such as ultrasonography, magnetic resonance imaging (MRI), or computed tomography (CT) may help characterize the lesion's depth, relationship to surrounding structures, and potential involvement of deeper tissues, particularly in larger, subcutaneous, or recurrent cases where more complex surgical planning is necessary.<xref ref-type="bibr" rid="article-151022.r20">[20]</xref>&#x000a0;Ultrasonography is often used as an initial imaging modality due to its accessibility and ability to assess superficial lesions; MRI or CT may provide additional information in cases of larger or deeper lesions.<xref ref-type="bibr" rid="article-151022.r21">[21]</xref>&#x000a0;While specific laboratory tests are not typically indicated for evaluating chondroid syringoma, a complete blood count and a comprehensive metabolic panel may be performed as part of a preoperative assessment or to&#x000a0;evaluate any underlying systemic conditions.</p>
      </sec>
      <sec id="article-151022.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Chondroid syringoma treatment typically involves surgical excision, which is considered curative in most cases.<xref ref-type="bibr" rid="article-151022.r10">[10]</xref>&#x000a0;The primary goal of surgical intervention is complete removal of the tumor with adequate margins to minimize the risk of recurrence and, although extremely rare, avoid malignant transformation. The extent of excision depends on factors such as tumor size, location, and depth of invasion. While chondroid syringoma is generally well-demarcated and encapsulated, careful dissection is essential to prevent damage to surrounding structures and ensure complete excision.</p>
        <p>Moreover, although recurrence rates following surgical excision are generally low, the possibility of recurrence necessitates long-term surveillance and follow-up care to ensure optimal patient outcomes. Recurrent lesions may require additional surgeries, potentially increasing patient morbidity and healthcare costs. In cases where surgical excision is not feasible due to tumor size, location, recurrence, or patient comorbidities, alternative treatment modalities such as Mohs micrographic surgery or radiation therapy may be considered.<xref ref-type="bibr" rid="article-151022.r22">[22]</xref>&#x000a0;However, the efficacy of these approaches in chondroid syringoma management remains less established, and further research is needed to delineate their role.</p>
        <p>Due to its rarity, guidelines for the management of patients with chondroid syringoma are limited. Therefore, treatment decisions are typically guided by expert consensus and clinical experience. Histopathological examination of the excised specimen is essential for confirming the diagnosis and assessing margins to ensure complete tumor removal. Genetic studies and immunohistochemical markers may provide insights into tumor behavior and aid in risk stratification.</p>
      </sec>
      <sec id="article-151022.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>When evaluating a patient with a suspected chondroid syringoma, it is essential to consider a range of differential diagnoses due to its nonspecific clinical presentation. Key conditions to include in the differential diagnosis to ensure accurate identification and management include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Epidermal inclusion cyst:</bold> A benign entity, which chondroid syringoma is often misdiagnosed as, based on clinical features</p>
          </list-item>
          <list-item>
            <p><bold>Eccrine spiradenoma:</bold> Another benign adnexal tumor originating from eccrine sweat glands, which can resemble chondroid syringoma histologically</p>
          </list-item>
          <list-item>
            <p><bold>Trichoepithelioma:</bold> A benign hair follicle tumor that may show overlapping histological features with chondroid syringoma, including basaloid cells and myxoid stroma</p>
          </list-item>
          <list-item>
            <p><bold>Pilomatricoma:</bold> A benign skin tumor derived from hair matrix cells, which may exhibit calcification and chondroid differentiation histologically</p>
          </list-item>
          <list-item>
            <p><bold>Dermatofibroma:</bold> A common benign skin lesion that can sometimes mimic chondroid syringoma clinically, especially when presenting as a firm, nodular lesion</p>
          </list-item>
          <list-item>
            <p><bold>Dermatofibrosarcoma protuberans:</bold> A rare, locally aggressive soft tissue tumor that may share histological similarities with chondroid syringoma, such as a storiform pattern</p>
          </list-item>
          <list-item>
            <p><bold>Adnexal carcinomas (eccrine carcinoma, apocrine carcinoma):</bold> Malignant adnexal tumors that may resemble chondroid syringoma histologically, particularly in cases of poorly differentiated or metastatic carcinoma</p>
          </list-item>
          <list-item>
            <p><bold>Basal cell carcinoma:</bold> The most common malignant skin tumor, which may display diverse histological patterns, including those resembling chondroid syringoma, such as cribriform or trabecular patterns</p>
          </list-item>
          <list-item>
            <p><bold>Cutaneous metastases:</bold>&#x000a0;Cutaneous metastases from various internal malignancies can mimic chondroid syringoma clinically and histologically (rare)</p>
          </list-item>
          <list-item>
            <p><bold>Neurofibroma:</bold> A benign peripheral nerve sheath tumor occasionally demonstrates histological overlap with chondroid syringoma, particularly in cases with myxoid stroma</p>
          </list-item>
          <list-item>
            <p><bold>Syringoma:</bold> A benign tumor of eccrine sweat duct origin, which can mimic chondroid syringoma clinically, especially in cases presenting as multiple, small papules</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-151022.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Chondroid syringoma typically carries an excellent long-term prognosis due to its benign nature, particularly when the tumor is diagnosed early and fully excised. Complete surgical removal usually leads to resolution without significant long-term complications.<xref ref-type="bibr" rid="article-151022.r23">[23]</xref>&#x000a0;Although it may occasionally recur after surgical excision, recurrence rates are low, ranging from 2% to 9%, according to various study results.<xref ref-type="bibr" rid="article-151022.r22">[22]</xref><xref ref-type="bibr" rid="article-151022.r24">[24]</xref><xref ref-type="bibr" rid="article-151022.r25">[25]</xref>&#x000a0;</p>
        <p>The risk of malignant transformation is exceedingly rare, with only a few documented cases reported in the literature.<xref ref-type="bibr" rid="article-151022.r25">[25]</xref><xref ref-type="bibr" rid="article-151022.r26">[26]</xref>&#x000a0;Malignant chondroid syringoma most commonly occurs on the extremities.<xref ref-type="bibr" rid="article-151022.r20">[20]</xref>&#x000a0;Furthermore, metastasis has not been observed in chondroid syringoma.</p>
      </sec>
      <sec id="article-151022.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications associated with chondroid syringoma are generally rare due to its benign nature; however, certain factors can lead to potential challenges in management. First, misdiagnosis or delayed diagnosis may occur due to the rarity of this condition and its varied clinical presentation, potentially resulting in inappropriate treatment or unnecessary patient anxiety. Moreover, incomplete excision of the tumor during surgery can lead to recurrence, albeit infrequent, requiring additional interventions and potentially impacting patient outcomes. Careful surgical planning and meticulous dissection are essential to minimize the risk of recurrence. Surgical complications may include wound infection, hematoma formation, nerve injury, or cosmetic deformity&#x02014;particularly in cases involving lesions in cosmetically sensitive areas such as the face.</p>
      </sec>
      <sec id="article-151022.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>In patients with chondroid syringoma, consultation with a dermatologist is crucial for accurate diagnosis and initial management. If the tumor is located in a cosmetically sensitive area, such as the face or neck, involving a plastic surgeon is advisable to ensure optimal cosmetic outcomes during surgical excision. Pathology consultation is also essential to distinguish chondroid syringoma from other benign and malignant neoplasms through histopathological examination. In rare cases of suspected malignancy or when the tumor exhibits atypical features, an oncologist may be consulted for further evaluation and management. Multidisciplinary collaboration enhances patient care and treatment outcomes.</p>
      </sec>
      <sec id="article-151022.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education is integral in managing chondroid syringoma, facilitating informed decision-making, reducing anxiety, and promoting adherence to treatment and follow-up care. By providing comprehensive education encompassing the nature of the condition, diagnostic process, treatment options, post-treatment care, and psychosocial support, healthcare professionals can empower patients to participate in their care journey and actively achieve optimal outcomes.</p>
        <p>Patients should understand&#x000a0;the benign nature of chondroid syringoma and that simple excision is essentially curative, with low recurrence rates after surgical excision. Histological characteristics and typical clinical presentation should be explained to facilitate patient education. Guidance on wound care, pain management, and expected postoperative recovery should be provided to ensure optimal healing outcomes. Patients should also be educated about signs of infection or recurrence warranting medical attention.</p>
      </sec>
      <sec id="article-151022.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Certain key insights can significantly improve diagnosis and treatment outcomes when managing care for patients with chondroid syringoma. Essential clinical pearls that&#x000a0;healthcare professionals should keep in mind to optimize patient care include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>This condition typically presents as a slow-growing, painless nodule, often on the head and neck.</p>
          </list-item>
          <list-item>
            <p>This is most commonly seen in middle-aged men.</p>
          </list-item>
          <list-item>
            <p>Early biopsy is essential for accurate diagnosis, as it can mimic other skin lesions.</p>
          </list-item>
          <list-item>
            <p>Differentiation from malignant chondroid syringoma and other neoplasms is critical.</p>
          </list-item>
          <list-item>
            <p>Surgical excision is the preferred treatment, aiming for complete removal to prevent recurrence.</p>
          </list-item>
          <list-item>
            <p>Consider a multidisciplinary approach to optimize functional and aesthetic outcomes, especially in cosmetically sensitive areas.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-151022.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Diagnosing and managing chondroid syringoma involves an interprofessional approach that combines the expertise of dermatologists, pathologists, surgeons, primary care clinicians, advanced care clinicians, nurses, pharmacists, and other healthcare professionals. This team works together to establish an accurate diagnosis using clinical assessment, possible imaging studies, and biopsies. This diagnostic process requires expertise in recognizing the varied clinical presentations and skills to perform a biopsy. Treatment typically involves surgical excision, with the team ensuring patient safety and providing comprehensive perioperative care.</p>
        <p>Care coordination includes managing pain, providing wound care, and monitoring the patient's recovery. Interprofessional communication is key to optimizing patient-centered care and outcomes. Team members share important information about the patient's condition and treatment plan, allowing for seamless collaboration.</p>
        <p>Ethical standards guide all healthcare professionals caring for patients with chondroid syringoma, prioritizing patient safety and informed consent. The team collaborates to deliver evidence-based treatment options and emotionally support patients and their families. By maintaining clear, open lines of communication and working cohesively, the interprofessional team can enhance patient-centered care, safety, and&#x000a0;clinical outcomes associated with chondroid syringoma.&#x000a0;</p>
      </sec>
      <sec id="article-151022.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=151022&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=151022">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/151022/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=151022">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-151022.s17">
        <fig id="article-151022.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Cutaneous Mixed Tumor. Conical nodule on the right cheek. Contributed by J McGetrick, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Mixed__tumor" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-151022.s18">
        <fig id="article-151022.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Cutaneous Mixed Tumor at 10x Magnification. Hematoxylin and eosin staining. Well-formed tubular and duct-like sweat gland structures proliferate within and adjacent to a mucoid and chondroid stroma. Contributed by A Church, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MIXED__TUMOR__10X" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-151022.s19">
        <fig id="article-151022.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Cutaneous Mixed Tumor at 2x Magnification. Hematoxylin and eosin staining. Well-formed tubular and duct-like sweat gland structures proliferate within and adjacent to a mucoid and chondroid stroma. No significant atypia is evident. Contributed by A Church, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MIXED__TUMOR__2X" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-151022.s20">
        <title>References</title>
        <ref id="article-151022.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sivamani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wadhera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma: case report and review of the literature.</article-title>
            <source>Dermatol Online J</source>
            <year>2006</year>
            <month>Sep</month>
            <day>08</day>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>8</fpage>
            <pub-id pub-id-type="pmid">16962023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sulochana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Manoharan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anitha</surname>
              </name>
            </person-group>
            <article-title>Chondroid syringoma-an unusual presentation.</article-title>
            <source>J Clin Diagn Res</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>7</issue>
            <fpage>FD13</fpage>
            <page-range>FD13-4</page-range>
            <pub-id pub-id-type="pmid">25177574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>HEADINGTON</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Mixed tumors of skin: eccrine and apocrine types.</article-title>
            <source>Arch Dermatol</source>
            <year>1961</year>
            <month>Dec</month>
            <volume>84</volume>
            <fpage>989</fpage>
            <page-range>989-96</page-range>
            <pub-id pub-id-type="pmid">13905736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>HIRSCH</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>HELWIG</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma. Mixed tumor of skin, salivary gland type.</article-title>
            <source>Arch Dermatol</source>
            <year>1961</year>
            <month>Nov</month>
            <volume>84</volume>
            <fpage>835</fpage>
            <page-range>835-47</page-range>
            <pub-id pub-id-type="pmid">13907712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martora</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mascolo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fabbrocini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Annunziata</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Picone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>DE Fata Salvadores</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Marasca</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma: an asymptomatic benign tumor.</article-title>
            <source>Ital J Dermatol Venerol</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>157</volume>
            <issue>5</issue>
            <fpage>450</fpage>
            <page-range>450-452</page-range>
            <pub-id pub-id-type="pmid">35274880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sami</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Jeyaraman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jeyaraman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Soft-tissue Chondroma Masquerading as Chondroid Syringoma - A Case Report.</article-title>
            <source>J Orthop Case Rep</source>
            <year>2024</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>92</fpage>
            <page-range>92-97</page-range>
            <pub-id pub-id-type="pmid">39253677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toper</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Sarioglu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.</article-title>
            <source>Adv Anat Pathol</source>
            <year>2021</year>
            <month>Mar</month>
            <day>01</day>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-93</page-range>
            <pub-id pub-id-type="pmid">33405400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turhan-Haktanir</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bukulmez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Demir</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma in a child.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2007</year>
            <season>Sep-Oct</season>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>505</fpage>
            <page-range>505-7</page-range>
            <pub-id pub-id-type="pmid">17958797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Purkayastha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wilson Jones</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma: an unusual presentation in a 7-year-old boy.</article-title>
            <source>BMJ Case Rep</source>
            <year>2021</year>
            <month>Jul</month>
            <day>26</day>
            <volume>14</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">34312123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Moreano</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Houston</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Funk</surname>
                <given-names>GF</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma of the head and neck: clinical management and literature review.</article-title>
            <source>Ear Nose Throat J</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>104</fpage>
            <page-range>104-8</page-range>
            <pub-id pub-id-type="pmid">8714424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yavuzer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ba&#x0015f;terzi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bir</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sezer</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma: a diagnosis more frequent than expected.</article-title>
            <source>Dermatol Surg</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-81</page-range>
            <pub-id pub-id-type="pmid">12562350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macagno</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sohier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kervarrec</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pissaloux</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jullie</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Cribier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Battistella</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors.</article-title>
            <source>Cancers (Basel)</source>
            <year>2022</year>
            <month>Jan</month>
            <day>18</day>
            <volume>14</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">35158743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aoun</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dufrenot-Petitjean-Roget</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Amazan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Derancourt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alexandre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quist</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Grossin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Molini&#x000e9;</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>[Cutaneous chondroid syringoma].</article-title>
            <source>Ann Pathol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>275</fpage>
            <page-range>275-80</page-range>
            <pub-id pub-id-type="pmid">26188668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Clinical and pathological study on mixed tumors of the skin.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>97</volume>
            <issue>36</issue>
            <fpage>e12216</fpage>
            <pub-id pub-id-type="pmid">30200138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kazakov</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Belousova</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Bisceglia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Calonje</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Emberger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grayson</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hantschke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kempf</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kutzner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Michal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spagnolo</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Virolainen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zelger</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Apocrine mixed tumor of the skin ("mixed tumor of the folliculosebaceous-apocrine complex"). Spectrum of differentiations and metaplastic changes in the epithelial, myoepithelial, and stromal components based on a histopathologic study of 244 cases.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>467</fpage>
            <page-range>467-83</page-range>
            <pub-id pub-id-type="pmid">17707152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kisova</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dikov</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ivanova</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stoyanov</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yordanova</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Mixed Eccrine Cutaneous Tumor with Folliculo-Sebaceous Differentiation: Case Report and Literature Review.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2023</year>
            <month>Aug</month>
            <day>16</day>
            <volume>59</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">37629755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kunikane</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ishikura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yoshiki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Itoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aizawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma (mixed tumor of the skin). A clinicopathological study of 13 cases.</article-title>
            <source>Acta Pathol Jpn</source>
            <year>1987</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>615</fpage>
            <page-range>615-25</page-range>
            <pub-id pub-id-type="pmid">2441570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lamba</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nanda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Chondroid Syringoma: Fine-needle Aspiration Cytology of a Rare Entity at an Unusual Site.</article-title>
            <source>J Clin Diagn Res</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>11</volume>
            <issue>7</issue>
            <fpage>ED06</fpage>
            <page-range>ED06-ED07</page-range>
            <pub-id pub-id-type="pmid">28892909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma of the axilla: A potential for misdiagnosis as metastatic carcinoma on fine needle aspiration cytology.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>50</volume>
            <issue>11</issue>
            <fpage>E315</fpage>
            <page-range>E315-E319</page-range>
            <pub-id pub-id-type="pmid">35748195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Most</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tai</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Atypical Chondroid Syringoma of the Toe.</article-title>
            <source>J Am Podiatr Med Assoc</source>
            <year>2023</year>
            <season>May-Jun</season>
            <volume>113</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">37463189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Min</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Byun</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Joo</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Chondroid Syringoma on Face.</article-title>
            <source>Arch Craniofac Surg</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-175</page-range>
            <pub-id pub-id-type="pmid">28913278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prajapati</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kunikullaya</surname>
                <given-names>US</given-names>
              </name>
            </person-group>
            <article-title>Chondroid syringoma of an upper eyelid tumor: Unusual case report.</article-title>
            <source>Indian J Cancer</source>
            <year>2023</year>
            <season>Apr-Jun</season>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>245</fpage>
            <page-range>245-247</page-range>
            <pub-id pub-id-type="pmid">36861706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Chondroid Syringoma of a Cheek.</article-title>
            <source>J Craniofac Surg</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>e480</fpage>
            <page-range>e480-e481</page-range>
            <pub-id pub-id-type="pmid">28582289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandeville</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Roh</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Woog</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Gonnering</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Mazzoli</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Ainbinder</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Older</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Moulin</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Kiel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YD</given-names>
              </name>
              <name>
                <surname>Dryja</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous benign mixed tumor (chondroid syringoma) of the eyelid: clinical presentation and management.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>110</fpage>
            <page-range>110-6</page-range>
            <pub-id pub-id-type="pmid">15083078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnett</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Wallack</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Zuretti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mesia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Emery</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Berson</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Recurrent malignant chondroid syringoma of the foot: a case report and review of the literature.</article-title>
            <source>Am J Clin Oncol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>227</fpage>
            <page-range>227-32</page-range>
            <pub-id pub-id-type="pmid">10857882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151022.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zufall</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Mark</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Gru</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Malignant chondroid syringoma: A systematic review.</article-title>
            <source>Skin Health Dis</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>e144</fpage>
            <pub-id pub-id-type="pmid">37013126</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
